ArticleInternational journal of women's health2026
Manifestations and Influencing Factors of Posttraumatic Growth Among Ovarian Cancer Patients Undergoing Chemotherapy: A Qualitative Exploration.
Article in International journal of women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This study aimed to explore the manifestations of posttraumatic growth (PTG) and its influencing factors among ovarian cancer patients undergoing chemotherapy. Methods: A descriptive qualitative study was employed. Between May 2023 and June 2024, 12 patients undergoing chemotherapy for ovarian cancer were recruited from a tertiary hospital in Hangzhou, China. Data were collected through semi-structured interviews and analyzed using conventional content analysis. Results: Three major themes and nine subthemes emerged: (1) Manifestations of PTG, including adopting healthy lifestyles, enhancing self-management awareness, maintaining a positive psychological state, and developing harmonious interpersonal relationships; (2) Facilitators of PTG, including medical resource accessibility, family support, and an optimistic personality; (3) Barriers to PTG, including family burden and conflict, and negative illness perception. Conclusion: PTG among ovarian cancer patients undergoing chemotherapy manifests as an integrated process of behavioral, psychological, and social adaptation. Family support and illness perception may modulate the degree of PTG. Future research should adopt multi-center and longitudinal designs to validate and extend these findings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.